| Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol DR Richardson, DJR Lane, EM Becker, MLH Huang, M Whitnall, ... Proceedings of the National Academy of Sciences 107 (24), 10775-10782, 2010 | 580 | 2010 |
| Iron uptake and metabolism in the new millennium LL Dunn, Y Suryo Rahmanto, DR Richardson Trends in cell biology 17 (2), 93-100, 2007 | 576 | 2007 |
| Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant MLH Huang, EM Becker, M Whitnall, Y Suryo Rahmanto, P Ponka, ... Proceedings of the National Academy of Sciences 106 (38), 16381-16386, 2009 | 234 | 2009 |
| Hepcidin, the hormone of iron metabolism, is bound specifically to α-2-macroglobulin in blood G Peslova, J Petrak, K Kuzelova, I Hrdy, P Halada, PW Kuchel, S Soe-Lin, ... Blood 113 (24), 6225-6236, 2009 | 212 | 2009 |
| Iron chelators for the treatment of cancer Y Yu, E Gutierrez, Z Kovacevic, F Saletta, P Obeidy, Y Suryo Rahmanto, ... Current medicinal chemistry 19 (17), 2689-2702, 2012 | 206 | 2012 |
| Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis B Guan, Y Suryo Rahmanto, RC Wu, Y Wang, Z Wang, TL Wang, IM Shih JNCI: Journal of the National Cancer Institute 106 (7), dju146, 2014 | 148 | 2014 |
| The MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation M Whitnall, Y Suryo Rahmanto, R Sutak, X Xu, EM Becker, MR Mikhael, ... Proceedings of the National Academy of Sciences 105 (28), 9757-9762, 2008 | 129 | 2008 |
| Loss of ARID1A in tumor cells renders selective vulnerability to combined ionizing radiation and PARP inhibitor therapy Y Park, MH Chui, Y Suryo Rahmanto, ZC Yu, RA Shamanna, MA Bellani, ... Clinical Cancer Research 25 (18), 5584-5594, 2019 | 121 | 2019 |
| Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti‐tumour efficacy Y Yu, Y Suryo Rahmanto, DR Richardson British journal of pharmacology 165 (1), 148-166, 2012 | 121 | 2012 |
| The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis LL Dunn, EO Sekyere, Y Suryo Rahmanto, DR Richardson Carcinogenesis 27 (11), 2157-2169, 2006 | 99 | 2006 |
| Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia M Whitnall, Y Suryo Rahmanto, MLH Huang, F Saletta, HC Lok, ... Proceedings of the National Academy of Sciences 109 (50), 20590-20595, 2012 | 96 | 2012 |
| Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1α and p53 F Saletta, Y Suryo Rahmanto, E Noulsri, DR Richardson Molecular pharmacology 77 (3), 443-458, 2010 | 87 | 2010 |
| The medicinal chemistry of novel iron chelators for the treatment of cancer Z Kovacevic, D S Kalinowski, D B Lovejoy, Y Yu, Y Suryo Rahmanto, ... Current topics in medicinal chemistry 11 (5), 483-499, 2011 | 86 | 2011 |
| The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich’s ataxia DR Richardson, MLH Huang, M Whitnall, EM Becker, P Ponka, ... Journal of molecular medicine 88 (4), 323-329, 2010 | 81 | 2010 |
| Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: long-lived NO that is trafficked by interacting proteins Y Suryo Rahmanto, DS Kalinowski, DJR Lane, HC Lok, V Richardson, ... Journal of Biological Chemistry 287 (10), 6960-6968, 2012 | 78 | 2012 |
| N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion DJR Lane, F Saletta, Y Suryo Rahmanto, Z Kovacevic, DR Richardson PloS one 8 (2), e57273, 2013 | 75 | 2013 |
| The translational regulator eIF3a: the tricky eIF3 subunit! F Saletta, Y Suryo Rahmanto, DR Richardson Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1806 (2), 275-286, 2010 | 74 | 2010 |
| Therapeutic inducers of apoptosis in ovarian cancer M Binju, MA Amaya-Padilla, G Wan, H Gunosewoyo, Y Suryo Rahmanto, ... Cancers 11 (11), 1786, 2019 | 73 | 2019 |
| The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark–from iron metabolism to tumorigenesis Y Suryo Rahmanto, LL Dunn, DR Richardson Oncogene 26 (42), 6113-6124, 2007 | 73 | 2007 |
| Nitric oxide storage and transport in cells are mediated by glutathione S-transferase P1-1 and multidrug resistance protein 1 via dinitrosyl iron complexes HC Lok, Y Suryo Rahmanto, CL Hawkins, DS Kalinowski, CS Morrow, ... Journal of Biological Chemistry 287 (1), 607-618, 2012 | 68 | 2012 |
